KayoThera is developing first-in-class, oral and safe antagonists of retinoid signaling, a pathway that was previously thought to be undruggable. KayoThera has developed a pipeline of potent drugs that inhibit […]
KayoThera is developing first-in-class, oral and safe antagonists of retinoid signaling, a pathway that was previously thought to be undruggable. KayoThera has developed a pipeline of potent drugs that inhibit […]